The event aims to bring together a highly targeted audience composed of experts, researchers, and early career trainees in drug discovery and development, in particular medicinal and synthetic chemists, together with scientists active in the fields of computer assisted drug design, biology, DMPK, pharmacology, and early toxicology.
Topics
- New Chemistries for the Preparation of DNA-Encoded Libraries
- Targeted Protein Degradation
- Recent Advances in Neurodegenerative Diseases
- Fragment Based Drug Discovery
- Protein-protein Interactions
- Emerging Synthetic Methodologies
- Targeting Immune Checkpoints with Small Molecules
- From RNA Targeting to Degraders and Beyond: Impact of Novel Modalities on Clinical Pipelines
Scientific Organizing Committee
- Iwan DE ESCH (Chair), Vrije Universiteit Amsterdam, The Netherlands
- Carolyn DZIERBA, Bristol-Myers Squibb, Cambridge, MA, United States
- Daniel HARKI, University of Minnesota, Minneapolis, United States
- Terry MOORE, University of Illinois, Chicago, United States
- Rita PETRACCA, Utrecht University, The Netherlands
- Greg SIEGAL, ZoBio BV, Leiden, The Netherlands
- Eddy SOTELO PÉREZ, Universidade de Santiago de Compostela, Spain
- Antonia F. STEPAN, F. Hoffmann-La Roche Ltd, Basel, Switzerland
- Luc VAN HIJFTE, Symeres, Nijmegen, The Netherlands
